Nimisha Rikhi
Emergent BioSolutions (United States)(US)Human Immunome Project(US)
Publications by Year
Research Areas
Influenza Virus Research Studies, Immunotherapy and Immune Responses, Immune Response and Inflammation, Respiratory viral infections research, Tuberculosis Research and Epidemiology
Most-Cited Works
- → CYLD Proteolysis Protects Macrophages from TNF-Mediated Auto-necroptosis Induced by LPS and Licensed by Type I IFN(2016)99 cited
- → The IκB Family Member Bcl-3 Coordinates the Pulmonary Defense against Klebsiella pneumoniae Infection(2011)29 cited
- → The NF‐κB regulator Bcl‐3 modulates inflammation during contact hypersensitivity reactions in radioresistant cells(2015)13 cited
- → Conserved Influenza Hemagglutinin, Neuraminidase and Matrix Peptides Adjuvanted with ALFQ Induce Broadly Neutralizing Antibodies(2021)8 cited
- → Real-time PCR of whole blood specimens transported in PrimeStore MTM® to detect and monitor MTB bacteremia(2016)3 cited
- → Unconjugated Multi-Epitope Peptides Adjuvanted with ALFQ Induce Durable and Broadly Reactive Antibodies to Human and Avian Influenza Viruses(2023)2 cited
- → Opsonic monoclonal antibodies enhance phagocytic killing activity and clearance of Mycobacterium tuberculosis from blood in a quantitative qPCR mouse model(2019)2 cited
- → P-1073. Developing Vaccines and Antibodies Targeting Conserved Peptidoglycan, Lipoteichoic Acid, and Lipopolysaccharide Epitopes to Combat Antimicrobial Resistance(2025)
- → Erratum to “Opsonic monoclonal antibodies enhance phagocytic killing activity and clearance of Mycobacterium tuberculosis from blood in a quantitative qPCR mouse model” [Heliyon 5 (9), (September 2019), e02260](2019)
- → P-43. A Single Composite Peptide Vaccine Comprising Conserved Influenza Epitopes Formulated with ALFQ Adjuvant Induced Broadly Reactive Antibodies to Human, Avian, and Swine Influenza Viruses(2025)